Why the study?
The study was conducted to explore the relationship between elevated BNP levels and prognosis in patients with infective endocarditis undergoing cardiac surgery.
Do elevated B-type natriuretic peptide (BNP) levels at admission predict all-cause mortality in patients with infective endocarditis undergoing cardiac surgery?
Do elevated B-type natriuretic peptide (BNP) levels at admission predict all-cause mortality in patients with infective endocarditis undergoing cardiac surgery?
Answers are grounded in this paper and cite their sources.
Elevated BNP levels at admission can serve as a prognostic biomarker for predicting all-cause mortality in patients with infective endocarditis undergoing cardiac surgery.
Purpose: The objective of this study was to explore the relationship between elevated B-type natriuretic peptide (BNP) levels and the prognosis of patients with infective endocarditis (IE) undergoing cardiac surgery.Methods: In total, 162 IE patients with recorded BNP levels upon admission were included in the present study. The primary end point was all-cause mortality.Results: Multivariate Cox analysis revealed a significant association between log BNP and all-cause mortality. Kaplan–Meier analysis revealed a poorer prognosis for patients with BNP levels ≥ the 75th percentile. Furthermore, the linear trend test indicated a significant link between BNP quartiles and the primary end point within the models.Conclusion: Elevated BNP levels upon admission could predict all-cause mortality in IE patients undergoing cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: